BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 30199584)

  • 1. The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review.
    Lerman DT; Hamilton KW; Byrne D; Lee DF; Zeitler K; Claridge T; Gray J; Minamoto GY
    Transpl Infect Dis; 2018 Dec; 20(6):e12995. PubMed ID: 30199584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Institutional volume of heart transplantation with left ventricular assist device explantation influences graft survival.
    Haglund NA; Feurer ID; Ahmad RM; DiSalvo TG; Lenihan DJ; Keebler ME; Schlendorf KH; Stulak JM; Wigger MA; Maltais S
    J Heart Lung Transplant; 2014 Sep; 33(9):931-6. PubMed ID: 24925183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation.
    Fudim M; Davis ME; Jenkins C; Brown CL; Wigger MA; Stulak JM; Maltais S; Haglund N
    Ann Thorac Surg; 2015 Dec; 100(6):2117-25; discussion 2125-6. PubMed ID: 26338051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation.
    Gaffey AC; Phillips EC; Howard J; Hung G; Han J; Emery R; Goldberg L; Acker MA; Woo YJ; Atluri P
    Ann Thorac Surg; 2015 Aug; 100(2):542-9. PubMed ID: 26070597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Renal Outcomes in Patients With Left Ventricular Assist Device and Heart Transplantation.
    Arshad A; Kew EP; Lim S
    Transplant Proc; 2019 Dec; 51(10):3395-3398. PubMed ID: 31810507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of patients with infection related to a ventricular assist device after heart transplantation.
    Moayedi Y; Multani A; Bunce PE; Henricksen E; Lee R; Yang W; Gomez CA; Garvert DW; Tremblay-Gravel M; Duclos S; Hiesinger W; Ross HJ; Khush KK; Montoya JG; Teuteberg JJ
    Clin Transplant; 2019 Oct; 33(10):e13692. PubMed ID: 31403741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.
    Alba AC; Tinckam K; Foroutan F; Nelson LM; Gustafsson F; Sander K; Bruunsgaard H; Chih S; Hayes H; Rao V; Delgado D; Ross HJ
    J Heart Lung Transplant; 2015 May; 34(5):685-92. PubMed ID: 25638296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Changes in Aortic Vascular Stiffness in Patients Bridged to Transplant With Continuous-Flow Left Ventricular Assist Devices.
    Patel AC; Dodson RB; Cornwell WK; Hunter KS; Cleveland JC; Brieke A; Lindenfeld J; Ambardekar AV
    JACC Heart Fail; 2017 Jun; 5(6):449-459. PubMed ID: 28285118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular assist device bridging to heart transplantation: Comparison of temporary versus durable support.
    Hess NR; Hickey GW; Keebler ME; Huston JH; McNamara DM; Mathier MA; Wang Y; Kaczorowski DJ
    J Heart Lung Transplant; 2023 Jan; 42(1):76-86. PubMed ID: 36182653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between continuous-flow left ventricular assist device infections requiring long-term antibiotic use and post-heart transplant morbidity and mortality.
    Lambadaris M; Vishram-Nielsen JKK; Amadio JM; Husain S; Rao V; Billia F; Alba AC
    J Card Surg; 2022 Jan; 37(1):96-104. PubMed ID: 34651943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
    Argenziano M; Catanese KA; Moazami N; Gardocki MT; Weinberg AD; Clavenna MW; Rose EA; Scully BE; Levin HR; Oz MC
    J Heart Lung Transplant; 1997 Aug; 16(8):822-31. PubMed ID: 9286774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices.
    Fraser CD; Zhou X; Magruder JT; Suarez-Pierre A; Lui C; Grimm JC; Higgins R; Kilic A
    J Card Surg; 2019 Jun; 34(6):474-481. PubMed ID: 31045281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Systemic and Device-Related Complications in Patients Bridged to Transplantation With Left Ventricular Assist Devices.
    Lui C; Suarez-Pierre A; Zhou X; Crawford TC; Fraser CD; Giuliano K; Hsu S; Higgins RS; Zehr KJ; Whitman GJ; Choi CW; Kilic A
    J Surg Res; 2020 Feb; 246():207-212. PubMed ID: 31605947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database.
    Healy AH; Baird BC; Drakos SG; Stehlik J; Selzman CH
    Ann Thorac Surg; 2013 Mar; 95(3):870-5. PubMed ID: 23218024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome.
    Takeda K; Takayama H; Colombo PC; Jorde UP; Yuzefpolskaya M; Fukuhara S; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 May; 34(5):667-74. PubMed ID: 25577566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Feasibility of Induction Immunosuppression When Driveline Infection Is an Indication for Cardiac Transplantation.
    Bhatia N; Voelkel AJ; Hussain Z; Sharma UC; Slaughter MS; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):675-83. PubMed ID: 26366889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.